Cargando…

Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy

Antibody-cytokine fusion proteins (immunocytokine) exert a potent anti-cancer effect; indeed, they target the immunosuppressive tumor microenvironment (TME) due to a specific anti-tumor antibody linked to immune activating cytokines. Once bound to the target tumor, the interleukin-2 (IL-2) immunocyt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mortara, Lorenzo, Balza, Enrica, Bruno, Antonino, Poggi, Alessandro, Orecchia, Paola, Carnemolla, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305397/ https://www.ncbi.nlm.nih.gov/pubmed/30619269 http://dx.doi.org/10.3389/fimmu.2018.02905

Ejemplares similares

Schedule-dependent therapeutic efficacy of L19mTNF-α and melphalan combined with gemcitabine
por: Mortara, Lorenzo, et al.
Publicado: (2013)

L19-IL2 Immunocytokine in Combination with the Anti-Syndecan-1 46F2SIP Antibody Format: A New Targeted Treatment Approach in an Ovarian Carcinoma Model
por: Orecchia, Paola, et al.
Publicado: (2019)

Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts
por: Orecchia, Paola, et al.
Publicado: (2015)

The immunological basis of tumor therapy by targeted delivery of TNFa to tumor vessels
por: Balza, Enrica, et al.
Publicado: (2006)

Overexpression of Murine Rnaset2 in a Colon Syngeneic Mouse Carcinoma Model Leads to Rebalance of Intra-Tumor M1/M2 Macrophage Ratio, Activation of T Cells, Delayed Tumor Growth, and Rejection
por: De Vito, Annarosaria, et al.
Publicado: (2020)

Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy
por: Albini, Adriana, et al.
Publicado: (2018)

Natural Killer Cells as Key Players of Tumor Progression and Angiogenesis: Old and Novel Tools to Divert Their Pro-Tumor Activities into Potent Anti-Tumor Effects
por: Bassani, Barbara, et al.
Publicado: (2019)

The Ovarian Cancer Tumor Immune Microenvironment (TIME) as Target for Therapy: A Focus on Innate Immunity Cells as Therapeutic Effectors
por: Baci, Denisa, et al.
Publicado: (2020)

Targeting of phosphatidylserine by monoclonal antibodies reverses an immunosuppressive checkpoint inducing innate and specific anti-tumor responses
por: Gong, Jian, et al.
Publicado: (2013)

The tumor innate immune microenvironment in prostate cancer: an overview of soluble factors and cellular effectors
por: Palano, Maria Teresa, et al.
Publicado: (2022)

Three-Dimensional Culture Models to Study Innate Anti-Tumor Immune Response: Advantages and Disadvantages
por: Poggi, Alessandro, et al.
Publicado: (2021)

The Hippo Pathway in Innate Anti-microbial Immunity and Anti-tumor Immunity
por: Zhang, Qian, et al.
Publicado: (2020)

Selective targeted delivery of the TNF-alpha receptor p75 and uteroglobin to the vasculature of inflamed tissues: a preliminary report
por: Ventura, Elisa, et al.
Publicado: (2011)

Anti-tumoral Effects of Recombinant Lactococcus lactis Strain Secreting IL-17A Cytokine
por: Jacouton, Elsa, et al.
Publicado: (2019)

Over-expressing Akt in T cells to resist tumor immunosuppression and increase anti-tumor activity
por: Wu, Yanhong, et al.
Publicado: (2015)

Innate and adaptive immunity contribute to the anti-tumor mechanisms of action of OncoVEX(mGM-CSF)
por: Cooke, Keegan, et al.
Publicado: (2015)

Cytokine IL-36γ Improves CAR T Cell Functionality and Induces Endogenous Anti-Tumor Response
por: Li, Xinghuo, et al.
Publicado: (2020)

Cytokine Profile in Lung Cancer Patients: Anti-Tumor and Oncogenic Cytokines
por: Essogmo, Freddy Elad, et al.
Publicado: (2023)

Innate Immune Training of Granulopoiesis Promotes Anti-tumor Activity
por: Kalafati, Lydia, et al.
Publicado: (2020)

Sindbis Virus with Anti-OX40 Overcomes the Immunosuppressive Tumor Microenvironment of Low-Immunogenic Tumors
por: Scherwitzl, Iris, et al.
Publicado: (2020)

Characterisation of innate lymphoid cell subsets infiltrating colorectal carcinoma
por: Carrega, Paolo, et al.
Publicado: (2020)

An IL-4/21 Inverted Cytokine Receptor Improving CAR-T Cell Potency in Immunosuppressive Solid-Tumor Microenvironment
por: Wang, Yi, et al.
Publicado: (2019)

Editorial: The intricate innate immune-cancer cell relationship in the context of tumor angiogenesis, immunity and microbiota: The angiogenic switch in the tumor microenvironment as a key target for immunotherapies
por: Mortara, Lorenzo, et al.
Publicado: (2022)

Alternative Splicing of the Angiogenesis Associated Extra-Domain B of Fibronectin Regulates the Accessibility of the B-C Loop of the Type III Repeat 8
por: Ventura, Elisa, et al.
Publicado: (2010)

The role of innate immune cells in the tumor microenvironment and research progress in anti-tumor therapy
por: Lu, Chenglin, et al.
Publicado: (2023)

Innate Immune Response Regulation by the Human RNASET2 Tumor Suppressor Gene
por: Acquati, Francesco, et al.
Publicado: (2019)

Redefining innate natural antibodies as important contributors to anti-tumor immunity
por: Rawat, Kavita, et al.
Publicado: (2021)

Activation of Adaptive and Innate Immune Cells via Localized IL2 Cytokine Factories Eradicates Mesothelioma Tumors
por: Nash, Amanda M., et al.
Publicado: (2022)

Recognition of tumor cells by Dectin-1 orchestrates innate immune cells for anti-tumor responses
por: Chiba, Shiho, et al.
Publicado: (2014)

Engineered IL-21 Cytokine Muteins Fused to Anti-PD-1 Antibodies Can Improve CD8+ T Cell Function and Anti-tumor Immunity
por: Shen, Shanling, et al.
Publicado: (2020)

Anti-inflammatory cytokines IL-35 and IL-10 block atherogenic lysophosphatidylcholine-induced, mitochondrial ROS-mediated innate immune activation, but spare innate immune memory signature in endothelial cells
por: Li, Xinyuan, et al.
Publicado: (2019)

Cytokine-Induced Senescence in the Tumor Microenvironment and Its Effects on Anti-Tumor Immune Responses
por: Rentschler, Maximilian, et al.
Publicado: (2022)

Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors—A Strategy for Hematological Malignancies?
por: Klein, Klara, et al.
Publicado: (2021)

Innate Immunity Effector Cells as Inflammatory Drivers of Cardiac Fibrosis
por: Baci, Denisa, et al.
Publicado: (2020)

The IL-10 polarized cytokine pattern in innate and adaptive immunity cells contribute to the development of FVIII inhibitors
por: Silveira, Amanda CO, et al.
Publicado: (2015)

IL-35 Is a Novel Responsive Anti-inflammatory Cytokine — A New System of Categorizing Anti-inflammatory Cytokines
por: Li, Xinyuan, et al.
Publicado: (2012)

Integrin CD11b activation drives anti-tumor innate immunity
por: Schmid, Michael C., et al.
Publicado: (2018)

Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity
por: Flint, Thomas R., et al.
Publicado: (2016)

Study on relationship between elderly sarcopenia and inflammatory cytokine IL-6, anti-inflammatory cytokine IL-10
por: Rong, Yu-Dong, et al.
Publicado: (2018)

Targeting Immunosuppressive Tumor-Associated Macrophages Using Innate T Cells for Enhanced Antitumor Reactivity
por: Li, Yan-Ruide, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qvs5908rcdsbjmc6fmbmq9hipp